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resumo 
 
 
A fosforilação proteica reversível é o principal mecanismo que regula as funções 
vitais dos espermatozoides, uma vez que, os espermatozoides são altamente 
compartimentados e praticamente desprovidos de transcrição e tradução. No 
entanto, existe uma pequena área de cromatina descondensada, na qual a 
transcrição e tradução ainda são possíveis. Existe apenas um estudo na 
literatura a demonstrar que ocorre síntese proteica nos espermatozoides 
durante a capacitação. 
O principal objetivo deste trabalho foi avaliar se a síntese proteica ocorre em 
espermatozoides de bovino e de humano. Deste modo, monitorizámos a síntese 
proteica, utilizando a técnica Surface Sensing of Translation (SUnSET), seguida 
de citometria de fluxo. Os resultados revelaram tradução de mRNA nos 
espermatozoides. Para além disso, avaliamos o impacto da inibição da tradução 
pelos ribossomas mitocondriais e citoplasmáticos nos níveis de expressão de 
diversas proteínas do espermatozoide. Os resultados demonstraram que, 
enquanto algumas proteinas são afetadas pelos inibidores da tradução, outras 
mantêm-se estáveis. 
Concluindo, os nossos resultados suportam que ocorre síntese proteica nos 
espermatozoides e demonstram, pela primeira vez, que a técnica SUnSET 
permite monitorizar e quantificar a síntese global de proteínas em 
espermatozoides de mamíferos. 
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abstract 
 
Reversible protein phosphorylation is the key general mechanism for regulating 
vital sperm cells functions since sperm cells are highly compartmentalized and 
almost devoid of transcription and translation. However, there is a small area of 
uncondensed chromatin where transcription and translation are still possible. 
There is only one study in the literature showing protein synthesis occurs in 
spermatozoa during capacitation.   
The main goal of this work was to study if protein translation occurs, both in 
human and bovine spermatozoa. In order to achieve that, we monitored protein 
synthesis using the Surface Sensing of Translation (SUnSET) technique, 
followed by flow cytometry. The results revealed mRNA translation in 
spermatozoa. Furthermore, we analysed the impact of translation inhibition by 
mitochondrial and cytoplasmic ribosomes in the expression levels of diverse 
spermatozoa proteins. The results show that, while some proteins are affected 
by translation inhibitors, others remain stable.  
To conclude, our results support protein synthesis occurs in spermatozoa and 
show, for the first time, SUnSET technique allows to monitor and quantify the 
global protein synthesis in mammalian spermatozoa. 
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1. Introduction 
1.1. Male Reproductive System 
The male reproductive system is involved in spermatogenesis and steroidogenesis, 
production of spermatozoa and male sex hormones, respectively; in addition to the 
delivery of sperm to the female reproductive tract. This system is composed by two testes; 
a system of genital ducts formed by the epididymis, vas deferens and ejaculatory duct; 
accessory sex glands as the seminal vesicles, prostate, and bulbourethral glands; and the 
penis 1. 
 
1.2. Testis 
Testis are oval shaped reproductive organs, located inside detached compartments within 
the scrotum, whose main roles are testosterone secretion, along with sperm production 1–
3. The testicular parenchyma consists in highly-coiled seminiferous tubules, the testis’ 
functional unit , where spermatogenesis occurs 1,4; surrounded by interstitial tissue, made 
of Leydig cells, responsible for testosterone secretion 1. 
The seminiferous epithelium is formed by a stratified layer of developing male germ cells 
(spermatogonia, spermatocytes and spermatids) and Sertoli cells, its only somatic cells, 
which keep germ cells nourished and organized 2.  
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Figure 1- Testis and epididymis structure. The testicular parenchyma contains highly-coiled 
seminiferous tubules. The accessory ducts shown are the epididymis and vas deferens.  
Adapted from 5,6. 
 
1.2.1. Sertoli Cells  
Sertoli cells are heavily involved in testis’ development and maturation 7. At the onset of 
puberty, these cells cease mitosis and their number is indispensable in regulation of 
spermatogenesis and testis size 8,9. 
Sertoli cells are nurse-like somatic cells, essential for spermatogenesis, since they extend 
from the base to the lumen of the seminiferous tubule, allowing them to support and 
nurture germ cells survival and maturation, as they pass through the seminiferous 
epithelium. These cells secrete glycoproteins and other important biomolecules such as 
transport or bioprotective proteins as transferrin; protease inhibitors, vital in tissue 
remodeling processes during spermiation; glycoproteins that form the basement 
membrane between the Sertoli cells and the peritubular cells; a class of regulatory 
glycoproteins that function as growth factors or paracrine factors; bioactive peptides, 
nutrients or metabolic intermediates 4,8,10.  
Furthermore, Sertoli cells aid spermatozoa detachment at spermiation and establish the 
blood–testis barrier, a physical barrier that isolates meiotic and post-meiotic germ cells 
from immune and lymphatic systems 4.  
 
1.2.2. Leydig Cells  
In humans, Leydig cells are split in two distinctive populations: fetal (FLCs) and adult Leydig 
cells (ALCs) 11. FLCs develop under the stimulation of placental human chorionic 
gonadotropin (hCG), responsible for testosterone production and testis descent 11,12. ALCs 
derive from Leydig stem cells and produce testosterone, in the presence of Luteinizing 
hormone (LH), which starts at puberty, fundamental in the establishment and maintenance 
of secondary sex characteristics and spermatogenesis continuity 10,13. 
These cells exist in the interstitial space, adjacent to blood vessels. Its main function is 
testosterone production, which diffuses into the seminiferous tubules 10.  
 
 1. Introduction 
 
3 
1.2.3. Spermatogenesis 
Spermatogenesis is the complex process of spermatozoa production, that occurs in the 
seminiferous tubules. It starts in puberty and lasts the rest of the male’s lifetime 1,2,10,14,15. 
Spermatogenesis is essential to preserve the number of chromosomes in the offspring, as 
it is responsible for the cell division of diploid spermatogonia into haploid gametes. 
It requires hormones as follicle stimulating hormone (FSH), LH and testosterone, essential 
to maintain spermatogenesis. Furthermore, Sertoli cells, which modify rates of 
spermatozoal production and produce key factors to gamete development 1,4,10. 
The entire process of spermatogenesis can be divided into three phases 1. The first phase, 
spermatocytogenesis is the process that starts with spermatogonium and finishes with 
spermatids. Firstly, diploid spermatogonia divides by mitoses, producing primary 
spermatocytes and other spermatogonia. After puberty, primary spermatocytes through 
meiosis originate haploid secondary spermatocytes, that later suffer meiosis, dividing into 
haploid spermatids 1. 
The second phase, spermiogenesis is the maturation of spermatids into haploid 
spermatozoa, regulated by testosterone that helps remove the residual bodies (excess 
organelles and cytoplasm) via phagocytosis, by adjacent Sertoli cells. The spermatozoon 
maturation involves the development of the axoneme, flagellum formation, nuclear 
maturation that includes condensation and packaging of DNA, initially with basic proteins, 
afterwards with protamines. The resultant chromatin is then enveloped by a Golgi 
apparatus creating the acrosome 1,15. 
The third phase, spermiation refers to the release of mature spermatozoa from the 
protective Sertoli cells into the lumen of the seminiferous tubule, prior to their transition 
into the epididymis. It can last several days to complete. The mature motile spermatozoa 
is still unable to penetrate the oocyte 1,15. 
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Figure 2- Spermatogenesis. The testicular parenchyma contains highly-coiled seminiferous 
tubules; surrounded by interstitial tissue, made of Leydig cells. The seminiferous epithelium 
is formed by a stratified layer of developing male germ cells (spermatogonia, 
spermatocytes and spermatids) and Sertoli cells. Adapted from 16,17. 
 
1.3. Spermatozoa 
Sperm is a small, condensed cell, extremely specialized in fertilizing an egg 16. The 
mammalian spermatozoa is composed by a head and a flagellum 18, surrounded by the 
plasma membrane,  and has a specie-specific length 19. These cells are absent of 
cytoplasmic organelles such as endoplasmic reticulum and Golgi apparatus, which are 
unnecessary for DNA delivering to the egg 16. However, it contains mitochondrial and 
cytoplasmic ribosomes 20. 
1.3.1. Head 
The sperm head contains the acrosome, a condensed nucleus and a compartmentalized 
perinuclear cytoskeleton 18. 
The acrosome is a cap-like form, Golgi-derived, highly diverse structure that covers the first 
two thirds of the sperm head 19,21. It contains several hydrolytic enzymes that are key for 
the acrosome reaction (AR), which enables spermatozoa to penetrate the zona pellucida 
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and fuse with the oocyte membrane 19,21,22. 
The sperm nucleus contains highly condensed chromatin with the genetic information 19, 
involved by a redundant nuclear envelope and protected by the perinuclear theca, a 
condensed cytosolic protein layer 23,24. 
During the last phases of spermatogenesis, a structural chromatin change occurs. It is 
characterized by a partial replacement of histones for protamines, the main nuclear 
proteins of mature spermatozoa, increasing nuclear DNA condensation. Therefore, sperm’s 
genome remains inactive until it is deposited inside an egg, becoming reactivated 25,26. 
However, in the neck region of spermatozoa, a short linking segment between the sperm 
head and the flagellum, there is a small area of uncondensed chromatin where 
transcription, translation and protein-biosynthesis are still possible 19,27,28. 
 
1.3.2. Flagellum 
The flagellum, the longest sperm’s fraction 15,19, consists in connecting piece, midpiece, 
principal piece, and end piece 19,29. 
The connecting piece is the small linkage, between the sperm head and the midpiece of the 
flagellum, which looks vital in stabilizing the proximal part of the sperm tail 29. 
The axoneme is a 9+2 (nine doublet microtubules surrounding a central pair) structure, 
required for male fertility and sperm motility. This structure extends all throughout 
flagellum’s length. The nine doublet microtubules are linked around the axoneme by nexin 
links 30–32. Inner and outer dynein arms, indispensable for flagellum movement, project 
from each of the nine outer doublets 31,32. Furthermore, nine radial spokes project inwards 
towards the central pair 30,31. 
The midpiece is characterized by a mitochondrial sheath (MS) that envelops nine 
morphologically different outer dense fibers (ODFs). Each ODFs is linked to its own 
axonemal doublet microtubule 31. Mitochondria is exclusive to the midpiece and produces 
ATP, via oxidative phosphorylation (OXPHOS) 33,34. It is split in four defined inter-connected 
compartments: the outer mitochondrial membrane (OMM), the inner mitochondrial 
membrane (IMM), the intermembrane space and the mitochondrial matrix 33. Mature 
mammalian sperm include a small number of mitochondria, between 22 to 75, which form 
 1. Introduction 
 
6 
a tight helix around the flagellar basis of the midpiece, strategically placed in order to 
provide the ATP necessary for flagellar propulsion 16,35–37. Mammalian mitochondrial 
ribosomes (mitoribosomes) have a 55 sedimentation coefficient (55S), which splits into a 
28S small subunit, which contains 12S rRNA; and a 39S large subunit, which has 16S rRNA 
38. In eukaryotic cells, mitochondria-type ribosomes are present outside mitochondria 39. A 
unique mitochondria feature is its own circular genome, mitochondrial DNA (mtDNA) and 
specific ribosomes, therefore enabling local protein synthesis 33,40. Each mitochondria has 
one copy of mtDNA 38,41. 
Furthermore, sperm mitochondria possess numerous exclusive proteins or protein 
isoforms 34. Even though, mtDNA simply codes for 13 polypeptides, producing five proteins 
overall, tens of proteins are synthesized during sperm capacitation 38. 
The principal piece , the longest flagellum’s fraction, is constituted by fibrous sheath (FS) 
ribs which enclose the dense fibers, along with two longitudinal FS columns that replace 
two ODFs 31,42. 
The endpiece only includes the axoneme, surrounded by the plasma membrane 31,34,43. 
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Figure 3- Spermatozoon structure and flagellum ultrastructure. The flagellum consists in 
connecting piece, midpiece, principal piece, and end piece. The connecting piece is the 
smallest flagellum’s fraction. The midpiece is characterized by a MS that envelops nine 
morphologically different ODFs and the axoneme. The principal piece is constituted by FS 
ribs which enclose the dense fibers, along with 2 longitudinal FS columns that replace two 
ODFs. The endpiece includes the axoneme, enclosed by the plasma membrane. Adapted 
from 5,17. 
 
1.4. Protein translation in spermatozoa 
Reversible protein phosphorylation is the key general mechanism for regulating vital sperm 
cells functions since sperm cells are highly compartmentalized and almost devoid of 
transcription and translation 44. However, in the neck region of spermatozoa, there is a 
small area of uncondensed chromatin where transcription, translation and protein-
biosynthesis are still possible 19,27,28. 
A new insight was given by Gur & Breitbart, which proved protein synthesis occurs in 
spermatozoa during capacitation, which is the sequence of biochemical and physiological 
changes, that occur in the female reproductive tract prior to the AR 20,38,45. 
They concluded sperm’s translation is time-dependent, capacitation-dependent and 
sensitive to mitochondrial translation inhibitors and insensitive to cytoplasmic translation 
inhibitor via inhibition of the incorporation of labeled [35S] amino acids into polypeptides 
during sperm capacitation 20,38. 
Furthermore, as expected by sperm’s morphology, BODIPY-lysine-tRNALys incorporation 
happens, apparently, in the sperm midpiece 20,38. In capacitating conditions, labeled amino 
acids incorporation started almost immediately, refuting previous thoughts 20,38,46. In fact, 
Gur & Breitbart believe, this newly made proteins, are indispensable to start and even 
continue sperm capacitation.  
Gur & Breitbart proposed mitoribosomes are responsible for sperm translation (Gur & 
Breitbart, 2006, 2008). Additionally, during capacitation, sperm-specific, nuclear-encoded, 
proteins were sensitive to the mitochondrial ribosome inhibitor 20,38.  
Inhibition of protein translation greatly reduced sperm functions, essential to fertilization 
such as motility, actin polymerization, and the AR 20. 
Translation was unaffected by transcription inhibitor, along with incorporation of labeled 
amino acids proving that the source for protein translation is long lasting mRNA 20,38.  
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In conclusion, since protein production in spermatozoa, revealed to be sensitive to several 
mitochondrial mRNA translation inhibitors, while insensitive to the cytoplasmic 80S 
ribosomal inhibitor, mitochondrial machinery is the responsible for sperm translation 20,38. 
Additionally, spermatozoa protein synthesis is key in the last maturation phase leading to 
successful fertilisation 20. 
 
 
Figure 4- The sperm protein translation model proposed by Gur & Breitbart. It suggests 
nuclear-encoded long lasting mRNA are translated by mitochondrial-type ribosomes 
localised both in the cytoplasm, outside and inside the mitochondria. The translated 
proteins are then translocated to their active site 38. Adapted from 38. 
 
1.4.1. Sperm RNA potential functions 
Although, it was originally believed sperm RNAs were merely spermatogenesis artefacts 28. 
Recent findings suggest otherwise, Hosken & Hodgson propose sperm RNA could have four 
potential functions such as relatedness markers, helping sperm cooperation; paternally 
established suppressors of haploid interests; nuptial gift, delivering the female with 
resources that attract her to fertilise; Trojan horse, given by males to manipulate female 
reproduction 47. 
They propose sperm RNA could act as relatedness markers that help sperm cooperation. 
Sperm cooperation, in other words, means mutual interaction between sperm of one male 
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to increase a male’s fertilization success48. 
The changes with morphology and motility in sperm microRNAs (miRNAs), whose role 
remains undetermined, indicate a critical biological function. Possibly they are remnants of 
spermatogenesis, stored for a later role in fertilization, or are delivered to the oocyte to 
guide early embryonic development 49. 
They also suggest sperm hypothetically could have some control over their own behavior 
47. Recent observations suggest that some transcription occurs in postmeiosis. For instance, 
in Drosophila melanogaster, it has been identified direct evidence for de novo transcription 
of RNA during the postmeiotic phases. Reinforcing the emerging notion that postmeiotic 
transcription is dynamic and integral to the overall process of spermatogenesis 50. Even 
though, it is controversial and possibly reveals translation of male transcripts packed into 
the gametes 51. 
It was also proposed that sperm acts as nuptial gifts, a method of male reproductive 
investment provided to females in return for mating 52. They are found across a large 
number of taxa, and males have been found to tailor these gifts in relation to the likelihood 
of siring success  52. However, females can accept gifts and use them in ways that do not 
benefit the gift provider  52. 
Furthermore, sperm could also act as Trojan horses delivering manipulative RNAs to 
influence female reproduction 47 since there are a lot of male-derived ejaculatory 
substances that alter female reproduction 53. 
These two last suggestions are the least likely, because the cost of packaging gifts into each 
spermatozoon will be wasted if only a few sperm fertilize ova 47. 
Additionally, Holman & Price suggested sperm RNA could intermediate an anticipatory 
paternal effect that encodes environmental information 54. Males possibly adjust the RNA 
content of their sperm under different conditions to prime the embryo to develop 
appropriately for the environment 55. 
Additionally, they proposed sperm RNA could originate from selfish genetic elements 
(SGEs), which promote their own transmission in ways that damage the fitness of the rest 
of the genome 56, or they probably represent a defense against SGEs 55. 
Lastly, they suggest sperm RNA may also trigger a male equivalent of Maternal-effect 
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dominant embryonic arrest (Medea) in Tribolium beetles 55. Medea is a maternal offspring 
killer that poisons all offspring, excluding those that inherit it and, therefore, have the 
antidote 56. 
All this lead us to think RNA sperm could be more important than originally believe (Table 
1). 
 
Table 1- Sperm RNA potential functions and matching descriptions 47,55. 
Sperm RNA potential functions Description 
Relatedness markers 
• Help sperm evolution and 
maintenance of cooperation 
• Results benefit group members 
• Via: 
o direct recognition 
o behavioral algorithm 
Paternally imposed suppressors of 
haploid interests 
• Suppress the selfish interests of the 
haploid cell 
• Keep sperm under paternal control 
Nuptial gift 
• Deliver resources to the female that 
attract her to fertilise 
Trojan horse 
• Manipulation of the female 
fertilisation machinery 
• Benefits the paternal haplotype 
Anticipatory paternal effect 
• Sperm RNA content varies under 
different conditions  
• Prime the embryo to develop 
properly for the environment 
SGEs 
• Promote their own transmission  
• Harm the fitness of the rest of the 
genome 56 
Defense against SGEs • Represent a protection against SGEs 
Male equivalent of Medea in Tribolium 
beetles 55 
• Medea is a maternal offspring killer  
• Poisons all offspring, excluding 
those that inherit it  
o have the antidote 56 
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1.5. Aims  
 
The main aim of this study was to evaluate protein synthesis in mammalian spermatozoa. 
In order to achieve that, we stablished a series of steps: 
• Monitoring and quantifying the global protein synthesis in human and bovine 
spermatozoa using Surface Sensing of Translation (SUnSET): 
o Preliminary assay in bovine and human spermatozoa 
o Positive control establishment 
o Protocol optimization in bovine spermatozoa 
o Flow Cytometry analysis 
• Assessing the expression levels of signalling proteins after treatment with 
translation inhibitors: 
o Bovine spermatozoa incubation, under capacitation conditions, with or 
without translation inhibitors (D-chloramphenicol or cycloheximide) 
o Immunoblots with antibodies for GSK-3∝/β, PPP1CC2, CaMKIV and HSP27 
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2. Material and methods 
 
Experimental procedures were performed in Signal Transduction Laboratory, Institute for 
Research in Biomedicine (iBiMED), University of Aveiro (Aveiro, Portugal). The details of the 
solutions used in this thesis are stated in the Supplementary Table 1. 
 
2.1. Sperm Sample Processing 
This study was approved by the Ethics and Internal Review Board of the Hospital Infante D. 
Pedro E.P.E. (Aveiro, Portugal) and was conducted in accordance with the ethical standard 
of the Helsinki Declaration. Ejaculated human semen samples from volunteer donors were 
collected by masturbation into a sterile container. All donor signed an informed consent 
allowing the use of the samples for scientific proposes. Basic semen analysis was conducted 
in accordance with World Health Organization (WHO) guidelines and only normal sperm 
samples were used. Briefly, after complete liquefaction of the semen samples at 37ºC, 
during approximately 30 minutes, a macroscopic examination was performed. The 
microscopic examination included the analysis of spermatozoa motility, concentration and 
morphology. All microscopy analyses were performed using a Zeiss Primo Star microscope 
(Carl Zeiss AG, Germany). The results of basic sperm analysis were detailed in 
Supplementary Table 2. 
Frozen semen from bulls was obtained from LusoGenes, LDA (Aveiro, Portugal). Bovine 
semen was thawed in a 37ºC water bath for 1 minute. 
Human and bovine spermatozoa were isolated and washed three times from seminal 
plasma by centrifugation (600g for 10 minutes at room temperature (RT)) using 1x 
Phosphate Buffered Saline (PBS). Pellet was re-suspended in Sperm Preparation Medium 
(SPM) (Origio, Denmark) to a final concentration desired and incubated at 37ºC with 5% 
CO2 until the appropriated treatments were added. The concentration of sperm cells after 
the washing procedures was assessed using the Sperm Class Analyzer CASA System 
(Microptic S L, Barcelona, Spain) with SCA® v5.4 software. Samples and controls (2 µl) were 
loaded into individual chambers of Leja Standard Count 8 chamber slide 20 µm depth (Leja 
Products B. V., The Netherlands) which were pre-heated at 37ºC. 
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2.2. Cell Culture 
CAL-1 and PNT2 cells were maintained in RPMI 1640 (GIBCO BRL Life Technologies, 
Rockville, MD) supplemented with 10% fetal calf serum (FCS, HyClone, PERBIO, Aalst, 
Belgium) and 1% penincillin/streptomycin mixture, maintained in a humidified atmosphere 
at 37°C and 5% CO2.  
CAL-1 (suspension) and PNT2 (adherent) cells were teased apart and washed by repeating 
pipetting in PBS, additionally PNT2 were harvested with trypsin (500 µl).  
 
2.3. Surface Sensing of Translation (SUnSET) 
 
2.3.1. Preliminary assay in bovine and human spermatozoa 
Bovine spermatozoa (5 x 106 cells or 20 x 106 cells) were incubated with puromycin (1 
µg/mL for 15 minutes or 10 µg/mL for 1 h) in a humidified atmosphere at 37°C and 5% CO2. 
Human spermatozoa (20 x 106 cells) were incubated with 10 μg/mL of puromycin for 1 h in 
a humidified atmosphere at 37°C and 5% CO2.  
Negative controls were performed in the absence of puromycin.  
The sperm cells were centrifuged 5 minutes at 500g and the supernatant was discarded. 
Cells were washed with PBS (5 minutes, 500g) and subsequently treated for Flow 
Cytometry analysis (see section 2.4.). 
 
2.3.2. Positive control establishment 
CAL-1 (suspension) and PNT2 (adherent) cells were used since translation is highly 
described in these cell types and they would, certainly, incorporate puromycin. 1 x 106 of 
each cell type was incubated for 15 minutes with 1 μg/mL of puromycin in a humidified 
atmosphere at 37°C and 5% CO2. 
For CAL-1 cells, the medium containing the cells was resuspended, transferred to a falcon 
and centrifuged at 1000 rpm for 3 minutes. 
For PNT2 cells, the medium was removed, and cells were washed with 2 mL of PBS. 500 µl 
of trypsin was added and incubated for 2 minutes in a humidified atmosphere at 37°C and 
5% CO2. Cells were transferred to a falcon and centrifuged at 1000 rpm for 3 minutes. 
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In both cells types, the supernatant was removed after centrifugation and the cells were 
subsequently used for Flow Cytometry analysis (see section 2.4.). 
 
2.3.3. Protocol optimization in bovine spermatozoa 
After the preliminary assays, a wide range of puromycin concentrations and incubation 
times were tested. 
Bovine sperm cells (20 x 106 cells) without treatment (negative control) or treated with five 
different puromycin concentrations (1; 5; 7,5; 10; 15 µg/mL) incubated for 15 or 30 minutes 
at 37°C and 5% CO2.  
A control condition was added: 20 x 106 cells of bovine sperm cells were incubated with 7,5 
µg /mL of puromycin and 100 µg /mL of D-CP, a specific inhibitor of mitochondrial 
translation 57. 
PNT2 cells were treated in parallel in 3 conditions: (1) negative control (incubated with 
RPMI 1640 (GIBCO BRL Life Technologies, Rockville, MD) supplemented with 10% foetal calf 
serum (FCS, HyClone, PERBIO, Aalst, Belgium) and 1% penincillin/streptomycin mixture); 
(2) positive control incubated with 1  µg /mL of puromycin concentration for 15 minutes at 
37°C and 5% CO2; (3) control incubated with 1  µg /mL of puromycin and 100 µg/mL of D-
CP, a specific inhibitor of mitochondrial translation 57, for 15 minutes at 37°C and 5% CO2.  
The sperm cells were centrifuged 5 minutes at 500g and the supernatant was discarded. 
Cells were washed with PBS (5 minutes, 500g) and subsequently treated for Flow 
Cytometry analysis (see section 2.4.). 
 
2.4. Flow Cytometry analysis 
Cells were fixed in 400 µl of 4% paraformaldehyde (PFA). Resuspended and incubated 15 
minutes at 37°C. Cells were harvested by centrifugation at 4 °C 300 g for 6 minutes. 
Discarded the supernatant, and washed three times with 400 μl of cold PBS. Cells were 
resuspended in 50 μl of Fluorescence activated cell sorting (FACS) solution including 0,1% 
saponin and transferred to a 96 round bottom well plates (Thermo Fisher Scientific). The 
plate was centrifuged at 4ºC 400 g for 3 minutes, discarded the supernatant and added 50 
μl of anti-puromycin Alexa488 (Thermo Fisher Scientific) diluted 1:100 in FACS solution 
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including 0,1% saponin. The negative control was incubated with only 50 μl of FACS solution 
including 0,1% saponin. Cells were resuspended and incubated 30 minutes on ice in the 
dark. Added 150 μl of FACS solution including 0,1% saponin. Resuspended and centrifuged 
4ºC 300g for 3 minutes and discarded the supernatant. Washed twice with 200 μl of FACS 
solution including 0,1% saponin. Washed once with 200 μl of cold PBS, resuspended the 
pellet in 200 μl of cold PBS. Filtered the samples and carried out a FACS analysis.  
Events were collected on a BD Accuri™ C6 Cytometer and the data was acquired and 
analysed using BD Accuri™ C6 software (BD Biosciences). 
 
2.5. Sperm treatment with translation inhibitors  
Bovine spermatozoa (20 x 106 cells) were incubated with D-CP, a specific inhibitor of 
mitochondrial translation 57 (100 µg/mL shortly (time 0) or for 4 h) or CH, a specific 
cytoplasmic ribosomal inhibitor 20 (1 mg/mL shortly (time 0) or for 4 h) in a humidified 
atmosphere at 37°C and 5% CO2. 
Negative controls were performed in the absence of D-CP, nor CH.  
The sperm cells were centrifuged 5 minutes at 500g and the supernatant was discarded. 
Cells were washed twice with PBS (5 minutes, 500g) and subsequently lysed with 60 μl of 
Sodium Dodecyl Sulfate (SDS) 1X on ice for 15 minutes.  
The sperm cells were centrifuged 4ºC 12000g for 10 minutes and the supernatant was kept. 
 
2.6. Western Blotting  
Sperm lysates were resolved by 10 % SDS - Polyacrylamide gel electrophoresis (PAGE) run 
at 200 V. Followed by electrotransference onto nitrocellulose membranes at 200 mA for 2 
hours. 8,75 x 106 sperm cells were loaded per condition/well. 
Membranes were later blocked with 5% Milk or 5% Bovine Serum Albumin (BSA) in Tris-
buffered saline containing 0,1% Tween 20 (TBST) 1X at RT for 1 h. The blots were washed 
with TBST and incubated with the following primary antibodies: mouse anti-Glycogen 
synthase kinase 3 (GSK-3α/β (0011-A): sc-7291 obtained from Santa Cruz Biotechnology, 
Inc.), mouse anti-protein 70 S6 kinase α (p70 S6 kα (B-5): sc-393967  obtained from Santa 
Cruz Biotechnology, Inc.), mouse anti- heat shock protein 27 (HSP27 (F-4): sc-13132) 
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overnight at 4ºC; mouse anti-Protein kinase C (PKC βI (E-3): sc-8049 obtained from Santa 
Cruz Biotechnology, Inc.), mouse anti- Ca2+/calmodulin- dependent protein kinase IV 
(CaMKIV (A-3): sc-166156 obtained from Santa Cruz Biotechnology, Inc.), at RT for 2h; 
rabbit anti- Phosphoprotein phosphatase 1  subunit gamma 2 (PPP1CC2) (homemade), at 
RT for 1h. 
Afterwards, the blots were washed three times with TBST for 10 minutes, followed by 
incubation with the proper secondary antibody (anti-mouse) for 1 hour at RT 
(IRDye®800CW anti-mouse (926-32210) secondary antibody (1:5000) obtained from LI-COR 
Biosciences (Lincon, NE, USA)).   
Blots were washed three times for 10 min with TBST and once with TBS and 
immunodetected using the Odyssey Infrared Imaging System (LI-COR® Biosciences, US).  
 
Table 2- Primary antibodies used for Immunoblotting 
Antibody Host Dilution 
Molecular 
Weight (kDa) 
Reference Supplier 
Anti-GSK-3α/β Mouse 1:1000 ~51/47 sc-7291 
Santa Cruz 
Biotechnology, Inc. 
Anti-PKC βI Mouse 1:800 ~79 sc-8049 
Santa Cruz 
Biotechnology, Inc. 
Anti-CaMKIV Mouse 1:800 ~60 sc-166156 
Santa Cruz 
Biotechnology, Inc. 
Anti-p70 S6 
kinase α 
Mouse 1:1000 ~70 sc-393967 
Santa Cruz 
Biotechnology, Inc. 
Anti-PPP1CC2 Rabbit 1:2000 ~37 G502 Homemade 
Anti-HSP 27 Mouse 1:1000 ~27 sc-13132 
Santa Cruz 
Biotechnology, Inc. 
 
 3. Results 
 
19 
3. Results 
 
3.1.  Strategy for protein synthesis analysis in human and bovine spermatozoa 
In order to explore the existence of protein synthesis in spermatozoa, a nonradioactive 
fluorescence-activated cell sorting–based alternative assay - Surface Sensing of Translation 
(SUnSET) - was used due to its useful ability of direct translation activity monitoring, in 
heterogenous cells populations, by flow cytometry 58.  
SUnSET takes advantage of the use of puromycin (puro), an aminonucleoside antibiotic 
produced by Streptomyces alboniger, structural analog of aminoacyl tRNAs, whose 
incorporation into the nascent polypeptide chain prevents elongation 58,59. Puromycin 
incorporation, when used in minimal quantities (< 10 μg/mL), directly echoes the rate of 
mRNA translation in vitro 58,60–62, detected and monitored by an anti-Puromycin staining. 
Our first challenge was to establish a suitable gate for bovine and human spermatozoa. As 
a result of the small dimension of this type of cells (Figure 5A and C), both axis (forward 
scatter (FSC) and side scatter (SSC)) demanded the use of a logarithmic scale, which aid the 
definition of both gates (Figure 5B and D). FSC reveals the cellular size, while SSC 
corresponds to cellular granularity or density 63. As demonstrated in Figure 5A and C, bovine 
spermatozoa samples are usually cleaner than human samples, which might contain other 
types of cells and cellular debris. In both populations (bovine and human) (Figure 5B and 
D), there is only one distinct population of cells. The gates were established where the 
population was denser, since the other smaller populations could represent cellular debris 
(Figure 5B and D). 
 
 3. Results 
 
20 
  
Figure 5- Bovine and Human spermatozoa density plots and gate establishment. Bovine (A) 
and Human (C) spermatozoa density plots (FSC vs. SSC in linear scale). Bovine and Human 
spermatozoa gate establishment (FSC and SSC in logarithmic scale) (B and D). FSC, forward 
scatter; SSC, side scatter. 
 
3.1.1. Positive control establishment  
Afterwards, two types of cell lines, suspension (CAL-1) and adherent cells (PNT2), were 
used to establish a positive control (PC) for this assay. Both cells lines (CAL-1 and PNT2) 
performed in a similar way, showing an identical shift, in the Puro-Alexa488 axis, in the 
overlay histograms, between the NC and puromycin 1 μg/mL condition (Figure 6A and B). 
Therefore, the PNT2 cell line was established as the PC, as it’s regularly used by our group. 
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Figure 6- Overlay histograms of CAL-1 and PNT2 cells. Two cell lines (CAL-1 and PNT2 cells) 
were treated with puromycin at a concentration of 1 µg/mL, for 15 min. The samples were 
left unstained (NC) or stained for anti-puromycin and analysed by flow cytometry. The plots 
represent the overlay histograms of CAL-1 (A) and PNT2 cells (B) between NC and 
puromycin samples. Puro, puromycin; NC, negative control. 
 
 
3.1.2. Protein synthesis in human spermatozoa 
To exploit if protein synthesis occurs in human spermatozoa, a concentration of 10 μg/mL 
of puromycin during 15 min was used. The results showed a shift between the NC and 
puromycin 10 μg/mL condition (Figure 7B). 
 
 
Figure 7- Overlay histograms of PNT2 cells and human spermatozoa. PNT2 cells (PC) and 
human spermatozoa and were treated with puromycin at a concentration of 1 µg/mL and 
10 µg/mL, respectively, for 15 min. The samples were left unstained (NC) or stained for 
anti-puromycin and analysed by flow cytometry. The plots represent the overlay 
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histograms of PNT2 cells (A) and human spermatozoa (B) between NC and puromycin 
samples. PC, positive control; NC, negative control; puro, puromycin. 
 
3.1.3. Protein synthesis in bovine spermatozoa 
To optimize the puromycin concentration, bovine spermatozoa were treated with two 
different concentrations of puromycin (1 μg/mL and 10 μg/mL) (Figure 8B). 
The shift in the Puro-Alexa488 axis, in the overlay histograms (Figure 8A and B) represent 
the increase of median fluorescence intensity (MFI) of puromycin showed in Figure 8C. 
Both concentrations of puromycin (1 μg/mL and 10 μg/mL) revealed a shift, between NC 
and puromycin-incubated samples (Figure 8B). Nevertheless, puromycin 10 μg/mL 
condition showed a greater increase in MFI (Figure 8C). 
As observed in Figure 8A, PNT2 cells (PC) MFI increase is much superior than bovine 
spermatozoa (Figure 8C). 
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Figure 8- Overlay and Puro (MFI) histograms of PNT2 cells and bovine spermatozoa. PNT2 
cells (PC) and bovine spermatozoa were treated with puromycin at a concentration of 1 
µg/mL; 1 and 10 µg/mL, respectively, for 15 min. The samples were left unstained (NC) or 
stained for anti-puromycin and analysed by flow cytometry. The plots represent the overlay 
histograms of PNT2 (A) and bovine spermatozoa (B) between NC and puromycin samples, 
represented in the Puro (MFI) histogram (C). MFI were normalised to the NC. Spz, 
spermatozoa; MFI, median fluorescence intensity; PC, positive control; puro, puromycin; 
NC, negative control. 
 
 
Subsequently, 5 different puromycin concentrations (1; 5; 7,5; 10; 15 μg/mL) were used, 
along with two incubation time (15 minutes or 30 minutes), in independent assays. 
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In both incubation times, all different puromycin concentrations (1; 5; 7,5; 10; 15 μg/mL) 
revealed a shift, comparing to the NC (Figure 9B and Figure 10 A).  
At 15 min, the biggest MFI increase was the puromycin 7,5 μg/mL condition (Figure 9C); 
while in the incubation of 30 min, it was the puromycin 5 μg/mL condition (Figure 10B). 
 
 
Figure 9- Overlay and Puro (MFI) histograms of PNT2 cells and bovine spermatozoa (15 
min). PNT2 cells (PC) and bovine spermatozoa were treated with puromycin at a 
concentration of 1 μg/mL and 1; 5; 7,5; 10; 15 μg/mL, respectively, for 15 min. The samples 
were left unstained (NC) or stained for anti-puromycin and analysed by flow cytometry. 
The plots represent the overlay histograms of PNT2 (A) and bovine spermatozoa (B) 
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between NC and puromycin samples, represented in the Puro (MFI) histogram (C). MFI 
were normalised to the NC. Spz, spermatozoa; MFI, median fluorescence intensity; PC, 
positive control; puro, puromycin; NC, negative control. 
 
 
 
Figure 10- Overlay and Puro (MFI) histograms of bovine spermatozoa (30 min). Bovine 
spermatozoa were treated with puromycin at a concentration of 1; 5; 7,5; 10; 15 μg/mL for 
30 min. The samples were left unstained (NC) or stained for anti-puromycin and analysed 
by flow cytometry. The plots represent the overlay histograms of bovine spermatozoa (A), 
represented in the Puro (MFI) histogram (B). The Puro (MFI) histogram (B) represents two 
independent experiments. MFI were normalised to the NC. Spz, spermatozoa; MFI, median 
fluorescence intensity; puro, puromycin; NC, negative control. 
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3.2. Impact of translation inhibition in bovine spermatozoa 
In order to test if D-CP, a specific inhibitor of mitochondrial translation 57 , reduces PNT2 
cells’ translation, 2 different time points were used (15 and 30 min). In both situations, MFI 
was similarly reduced (Figure 11A). 
Therefore, in order to test the translation inhibition in bovine spermatozoa, two incubation 
times (30 min and 4 h) were tested (Figure 11B). In both inhibition conditions (30 min and 
4 h), a puromycin concentration of 7,5 μg/mL was used, since it previously revealed to have 
the biggest protein translation rate (Figure 9C). Both D-CP conditions (30 min and 4 h) 
showed lower MFI levels, supporting D-CP as a translation inhibitor (Figure 11D) 20. D-CP 
treatment (4h) did not have a significative impact on sperm motility (Supplementary Table 
3). 
 
 
 
 3. Results 
 
27 
 
Figure 11- Overlay and Puro (MFI) histograms of PNT2 cells (D-CP 15 and 30 min) and bovine 
spermatozoa (D-CP 30 min and 4 h). PNT2 cells were treated with puromycin at a 
concentration of 1 μg/mL, and with D-CP for 15 min and 30 min (A); bovine spermatozoa 
were treated with 7,5 μg/mL puromycin and with or without D-chloramphenicol for 30 min 
or 4 h. The samples were left unstained (NC) or stained for anti-puromycin and analysed by 
flow cytometry. The plots represent the overlay histograms of PNT2 cells (A) and bovine 
spermatozoa (B), represented in the Puro (MFI) histogram (C and D). MFI were normalised 
to the NC; MFI levels with D-CP were normalised to the similar condition without the 
inhibitor. MFI, median fluorescence intensity; puro, puromycin; NC, negative control. 
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3.2.1. Impact of translation inhibition on the levels of several signaling proteins in 
bovine spermatozoa 
 
In order to identify differentially expressed proteins after translation inhibition, bovine 
spermatozoa were exposed, in capacitating conditions, along with two translation 
inhibitors for 4h named: (i) D-CP, a specific inhibitor of mitochondrial translation 57  and (ii) 
CH, a specific cytoplasmic ribosomal inhibitor 20.  
After exposure of bovine spermatozoa to D-CP and CH for 4h, a reduction in the levels of 
GSK-3α (Figure 12), PPP1CC2 (Figure 12) and HSP27 (Figure 13), was observed, compared 
with the negative control (NC) at 4h and the T0 conditions. Interestingly, the levels of GSK-
3α, PPP1CC2 and HSP27 were lower with the translation inhibitor CH than with D-CP. These 
results suggested that both mitochondrial and cytoplasmic ribosomes might be involved in 
protein translation in bovine spermatozoa, and GSK-3α, PPP1CC2 and HSP27 could be 
translated during sperm capacitation. 
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Figure 12- Immunoblot with mouse anti-GSK-3α/β and rabbit anti-PPP1CC2. Bovine sperm 
soluble extracts corresponding to 8,75 x 106 cells were loaded, followed by immunoblot 
with mouse anti-GSK-3α/β and rabbit anti-PPP1CC2 (A). Pixel intensity was quantified using 
Quantity One® Software (B and C) and Ponceau staining was used as loading control 
(Supplementary Figure 1A). GSK-3α graph bars represent the mean values of three 
independent experiments. PPP1CC2 graph bars represent the mean values of two 
independent experiments. NC, negative control; D-CP, D- Chloramphenicol; CH, 
cycloheximide; IB, immunoblot. 
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Figure 13- Immunoblot with mouse anti-HSP27. Bovine sperm soluble extracts 
corresponding to 8,75 x 106 cells were loaded, followed by immunoblot with mouse anti-
HSP27 (A). Pixel intensity was quantified using Quantity One® Software (B) and Ponceau 
staining was used as loading control (Supplementary Figure 1B). NC, negative control; D-
CP, D- Chloramphenicol; CH, cycloheximide; IB, immunoblot. 
 
On the other hand, following 4 hours incubation, neither D-CP, nor CH affected CaMKIV 
expression (Figure 14).  
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Figure 14- Immunoblot with mouse anti-CaMKIV. Bovine sperm soluble extracts 
corresponding to 8,75 x 106 cells were loaded, followed by immunoblot with mouse anti-
CaMKIV (A). Pixel intensity was quantified using Quantity One® Software (B) and Ponceau 
staining was used as loading control (Supplementary Figure 1C). NC, negative control; D-
CP, D- Chloramphenicol; CH, cycloheximide; IB, immunoblot. 
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4. Discussion 
 
Protein translation in spermatozoa remains a controversial subject, mainly due to sperm 
cell’s high compartmentalization 44, along with its lack of cytoplasmic organelles such as 
endoplasmic reticulum and Golgi apparatus 16. However, the presence of an area of 
uncondensed chromatin, in the neck region 19,27,28 , as well as mitochondrial and 
cytoplasmic ribosomes 20 increases the likelihood of protein translation in spermatozoa. 
A new insight was given by Gur & Breitbart, which proved protein synthesis occurs in 
spermatozoa during capacitation 20,38 through labeling of sperm’s nascent proteins via [35S] 
amino acid, which was completely inhibited by D-chloramphenicol (D-CP), while unaffected 
by Cycloheximide (CH). Furthermore, BODIPY-lysine-tRNALys incorporation allowed 
visualization of the translation’s progress 20,38, which, as expected by sperm’s morphology, 
occurs, apparently, in the sperm midpiece 20,38. Thereby, concluding sperm’s translation is 
time-dependent, capacitation-dependent and sensitive to mitochondrial translation 
inhibitors. 
To test that hypothesis, in this study we implemented, for the first time in bovine and 
human spermatozoa, a nonradioactive method to monitor protein synthesis named surface 
sensing of translation (SUnSET) 58. 
Our approach using the SUnSET technique revealed to be extremely enlightening, since it 
allowed to monitor the rate of mRNA translation in spermatozoa (Fig. 5-10) 58, by anti-
puromycin staining detection of puromycin incorporation in neosynthesized proteins, 
supporting that protein translation occurs in both bovine and human spermatozoa. 
Nevertheless, spermatozoa protein translation levels were significantly inferior when 
compared with somatic cells (PNT2) levels (Fig. 8). 
Bovine spermatozoa treated for 15 min with puromycin, presented the highest mRNA 
translation levels with a puromycin concentration of 7,5 μg/mL (Fig. 9); while, for a 
puromycin incubation of 30 min, the optimal puromycin concentration was 5 μg/mL (Fig. 
10). The 30 min incubation exhibited, in all conditions, higher protein translation levels than 
the 15 min incubation suggesting it is a better puromycin incubation time to measure 
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spermatozoa translation levels, since as described by Gur & Breitbart, translation levels 
increase until it reaches a plateau after 1 h of incubation under capacitation conditions 20. 
Therefore, further studies are indispensable to establish the absolute optimal puromycin 
concentration and incubation time to monitor protein synthesis in mammalian 
spermatozoa. 
Additionally, in order to corroborate Gur & Breitbart’s view that spermatozoa translation 
occurs in mitochondrial-type ribosomes 20, bovine spermatozoa was incubated with D-CP, 
which revealed, as expected, a decrease in protein translation (Fig. 11). However, the 
similar results obtained with D-CP incubated for 30 min and 4 h, display that short 
incubation times are enough for D-CP necessary inhibitor effect (Fig. 11D) 20. 
Furthermore, to determine if, not only mitochondrial-type ribosomes, but also cytoplasmic 
ribosomes are involved in spermatozoa translation, bovine spermatozoa were incubated 
under capacitation conditions with or without D-CP and CH. Sperm cells lysates were 
electrophoresed and transferred into nitrocellulose membranes and membranes were 
incubated with antibodies for GSK-3α, PPP1CC2, PKC βI (Supplementary Figure 2), CaMKIV, 
p70 S6 kinase α (Supplementary Figure 3) and HSP27. PPP1CC2 and GSK-3  are crucial for 
motility initiation in the epididymis, along with regulation of mature sperm functions 64,65; 
PKC is involved in flagellar motility and in the AR 66–68; CaMKIV was also previously described 
in the human sperm flagellum 69; p70 S6 kinase was reported to be a multifunctional 
protein that regulates spermatogenesis 70,71; HSP27 was reported in human spermatozoa 
and its activation is negatively correlated with motility 70. To our knowledge, it was the first 
time, HSP27 is identified in bovine spermatozoa. 
As expected, GSK-3α (Fig. 12) levels decline with D-CP treatment. However, they all 
exhibited, surprisingly, a greater decline with CH than D-CP. Therefore, these results defy 
Gur & Breitbart’s vision 20, suggesting that both mitochondrial and cytoplasmic ribosomes 
might be involved in spermatozoa protein translation. Our results support that GSK-3α is, 
as Gur & Breitbart previously suggested, translated during sperm capacitation 20. It was the 
first demonstration, that PPP1CC2 (Fig. 12) and HSP27 (Fig. 13) levels decline, when 
translation is inhibited, indicating for the first time, both proteins are translated during 
sperm capacitation. 
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On the other hand, CaMKIV levels remained constant with D-CP (Fig. 14), as described by 
Gur & Breitbart , along with CH treatment, indicating CaMKIV remains relatively stable 
during sperm capacitation 20. 
This study presented the first time the SUnSET technique was used to detect mRNA 
translation in spermatozoa. Additionally, PPP1CC2 and HSP27 were, for the first time, 
shown to be translated in spermatozoa during capacitation.  
Our results corroborate, by other method, the only published paper about spermatozoa 
protein translation conclusions, except, we show for the first time, cytoplasmic ribosomes 
are also responsible for spermatozoa protein synthesis. 
So, the initial key steps towards a change of believe about spermatozoa translation 
existence and importance were given. 
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5. Conclusions and future perspectives 
5.1. Conclusions 
 
The principal objective of this thesis was to demystify bovine and human spermatozoa 
protein translation using the SUnSET technique and Immunoblotting.  
It was first time the SUnSET technique was used to detect mRNA translation in 
spermatozoa. The optimization of the SUnSET technique in bovine spermatozoa was 
unprecedent, which effectively demonstrated spermatozoa protein translation. The higher 
protein translation levels were obtained with an incubation time of 30 min and a 5 μg/mL 
puromycin concentration. 
Immunoblotting results confirm, as previously described, GSK-3α is translated and CaMKIV 
is not. Furthermore, PPP1CC2 and HSP27 were, for the first time, shown to be translated in 
spermatozoa during capacitation. 
Furthermore, translation inhibitors D-CP and CH were successfully used, showing 
surprisingly both, mitochondrial and cytoplasmic ribosomes, are involved in spermatozoa 
protein translation (Fig. 12 and 13). 
However, due to spermatozoa anatomic features, spermatozoa protein translation levels 
are residual, when compared to somatic cell (PNT2) levels.  
Our results validate, by other method, the only published data about spermatozoa protein 
translation. Nevertheless, we exhibit for the first time, cytoplasmic ribosomes are also 
accountable for spermatozoa protein synthesis. 
In conclusion, this work proved protein translation occurs in bovine spermatozoa during 
capacitation. 
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Figure 15- New sperm protein translation model proposed. It suggests nuclear-encoded 
long lasting mRNA are translated by cytoplasmic ribosomes, localised in the cytoplasm; 
along with mitochondrial-type ribosomes, localised outside and inside the mitochondria. 
The translated proteins are then translocated to their active site 38. Adapted from 38. 
 
5.2. Future perspectives 
 
Upcoming work should focus upon the identification of the specific proteins translated in 
human spermatozoa during capacitation by mass spectrometry (MS), allowing also to 
validate if GSK-3α, PPP1CC2 and HSP27 are truly translated, while CaMKIV is not.  
The SUnSET bovine spermatozoa results demand the use of other translation elongation 
inhibitors, namely emetine, in place of cycloheximide, a competitive inhibitor of the 
puromycin reaction, in order to validate if both, mitochondrial and cytoplasmic ribosomes, 
are involved in spermatozoa protein translation 72–74. Furthermore, future replicas with 
human spermatozoa are essential to correlate if the results are similar to bovine 
spermatozoa.  
 
 
 
Protein translocation 
to their target site 
Protein 
translation 
Cytoplasm 
mRNA 
Nucleus 
Protein 
Long lasting 
mRNA 
  
 
39 
References 
 
1.  Jiménez-Reina L, Maarten PJ, Jimena-Medina I, Agarwal A, Plessis SS du. Overview of 
the Male Reproductive System. In: Exercise and Human Reproduction. ; 2016:1-17. 
doi:10.1007/978-1-4939-3402-7. 
2.  Shalet SM. Normal Testicular Function and Spermatogenesis. Pediatr Blood Cancer. 
2009;53:285-288. doi:10.1002/pbc. 
3.  Bhimji S, Leslei S. Anatomy, Pelvis, Testicle.; 2018. 
https://www.ncbi.nlm.nih.gov/books/NBK470201/. 
4.  Chojnacka K, Zarzycka M, Mruk DD. Molecular Mechanisms of Cell Differentiation in 
Gonad Development. 2016;58:225-251. doi:10.1007/978-3-319-31973-5. 
5.  Martini FH, Timmons MJ, Tallitsch RB. Human Anatomy. 7th ed. (Berriman L, ed.). 
Pearson Benjamin Cummings; 2012. 
6.  Marieb EN, Hoehn KN. Human Anatomy & Physiology. 9th ed. (Beauparlant S, ed.). 
Pearson Education, Inc; 2013. doi:10.1007/BF00845519. 
7.  Cortes D, Müller J, Skakkebaek NE. Proliferation of Sertoli cells during development 
of the human testis assessed by stereological methods. Int J Androl. 1987;10(4):589-
596. doi:10.1111/j.1365-2605.1987.tb00358.x. 
8.  Griswold MD. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol. 
1998;9(4):411-416. http://www.sciencedirect.com/science/article/B6WX0-
45M31XN-H/2/c374f4f58035a68d8b2a948d4cc365f0 
file://D:%5CPaper(pdf)%5CGriswold_1998.pdf. 
9.  Johnson L, Thompson DL, Varner DD. Role of Sertoli cell number and function on 
regulation of spermatogenesis. Anim Reprod Sci. 2008;105(1-2):23-51. 
doi:10.1016/j.anireprosci.2007.11.029. 
10.  Smith LB, Walker WH. The regulation of spermatogenesis by androgens. Semin Cell 
Dev Biol. 2014;30:2-13. doi:10.1016/j.semcdb.2014.02.012. 
11.  Tremblay JJ. Molecular regulation of steroidogenesis in endocrine Leydig cells. 
Steroids. 2015;103:3-10. doi:10.1016/j.steroids.2015.08.001. 
12.  Choi J, Smitz J. Luteinizing hormone and human chorionic gonadotropin: 
Distinguishing unique physiologic roles. Gynecol Endocrinol. 2014;30(3):174-181. 
doi:10.3109/09513590.2013.859670. 
13.  Walker WH. Testosterone signaling and the regulation of spermatogenesis. 
Spermatogenesis. 2011;1(2):116-120. doi:10.4161/spmg.1.2.16956. 
14.  Johnson L. Efficiency of spermatogenesis. Microsc Res Tech. 1995;32(5):385-422. 
doi:10.1002/jemt.1070320504. 
15.  Holstein A-F, Schulze W, Davidoff M. Understanding spermatogenesis is a 
prerequisite for treatment. Reprod Biol Endocrinol. 2003;16:1-16. doi:10.1186/1477-
7827-1-107. 
16.  Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Alberts - Molecular Biology 
Of The Cell 4th Ed. J Chem Inf Model. 1989;53:160. 
doi:10.1017/CBO9781107415324.004. 
17.  Fardilha M, Silva JV, Conde M. Reprodução Humana Masculina. 1st ed. (Fardilha M, 
Silva JV, Conde M, eds.). Aveiro: ARC Publishing e Editores; 2015. 
  
 
40 
18.  Fouquet JP, Kann ML. The cytoskeleton of mammalian spermatozoa. Biol Cell. 
1994;81(2):89-93. doi:10.1016/S0248-4900(94)80001-4. 
19.  Pesch S, Bergmann M. Structure of mammalian spermatozoa in respect to viability, 
fertility and cryopreservation. Micron. 2006;37(7):597-612. 
doi:10.1016/j.micron.2006.02.006. 
20.  Gur Y, Breitbart H. Mammalian sperm translate nuclear-encoded proteins by 
mitochondrial-type ribosomes. Genes Dev. 2006;20(4):411-416. 
doi:10.1101/gad.367606. 
21.  Berruti G, Paiardi C. Acrosome biogenesis. Spermatogenesis. 2011;1(2):95-98. 
doi:10.4161/spmg.1.2.16820. 
22.  Brucker C, Lipford GB. The human sperm acrosome reaction: physiology and 
regulatory mechanisms. An update. Hum Reprod. 1995;1(1):51-62. 
23.  Ho H-C, Suarez SS. Characterization of the Intracellular Calcium Store at the Base of 
the Sperm Flagellum That Regulates Hyperactivated Motility1. Biol Reprod. 
2003;68(5):1590-1596. doi:10.1095/biolreprod.102.011320. 
24.  Oko R, Sutovsky P. Biogenesis of sperm perinuclear theca and its role in sperm 
functional competence and fertilization. J Reprod Immunol. 2009;83(1-2):2-7. 
doi:10.1016/j.jri.2009.05.008. 
25.  Steger K. Transcriptional and translational regulation of gene expression in haploid 
spermatids. Anat Embryol (Berl). 1999;199(6):471-487. 
26.  Brewer L, Corzett M, Balhorn R. Condensation of DNA by spermatid basic nuclear 
proteins. J Biol Chem. 2002;277(41):38895-38900. doi:10.1074/jbc.M204755200. 
27.  Dadoune JP. Expression of mammalian spermatozoal nucleoproteins. Microsc Res 
Tech. 2003;61(1):56-75. doi:10.1002/jemt.10317. 
28.  Miller D, Ostermeier GC, Krawetz SA. The controversy, potential and roles of 
spermatozoal RNA. Trends Mol Med. 2005;11(4):156-163. 
doi:10.1016/j.molmed.2005.02.006. 
29.  Ounjai P, Kim KD, Lishko P V., Downing KH. Three-Dimensional Structure of the 
Bovine Sperm Connecting Piece Revealed by Electron Cryotomography. Biol Reprod. 
2012;87(3):1-9. doi:10.1095/biolreprod.112.101980. 
30.  Stephens RE, Oleszko-Szuts S, Linck RW. Retention of ciliary ninefold structure after 
removal of microtubules. J Cell Sci. 1989;92(3):391-402. 
http://jcs.biologists.org/content/92/3/391.abstract%5Cnpapers3://publication/uui
d/0E03A8B0-2464-40D7-91AC-1941F8F0FD3E. 
31.  Linck RW, Chemes H, Albertini DF. The axoneme: the propulsive engine of 
spermatozoa and cilia and associated ciliopathies leading to infertility. J Assist 
Reprod Genet. 2016;33(2):141-156. doi:10.1007/s10815-016-0652-1. 
32.  Inaba K. Molecular Architecture of the Sperm Flagella: Molecules for Motility and 
Signaling. Zoolog Sci. 2003;20(9):1043-1056. doi:10.2108/zsj.20.1043. 
33.  Amaral A, Lourenço B, Marques M, Ramalho-Santos J. Mitochondria functionality 
and sperm quality. Reproduction. 2013;146(5). doi:10.1530/REP-13-0178. 
34.  Turner RM. Moving to the beat: A review of mammalian sperm motility regulation. 
Reprod Fertil Dev. 2006;18(1-2):25-38. doi:10.1071/RD05120. 
35.  Bahr GF, Engler WF. Considerations of volume, mass, DNA, and arrangement of 
mitochondria in the midpiece of bull spermatozoa. Exp Cell Res. 1970;60(3):338-340. 
  
 
41 
doi:10.1016/0014-4827(70)90526-4. 
36.  St John JC, Sakkas D, Barratt CLR. A role for mitochondrial DNA and sperm survival. J 
Androl. 2000;21(2):189-199. 
37.  May-Panloup P, Chrétien MF, Savagner F, et al. Increased sperm mitochondrial DNA 
content in male infertility. Hum Reprod. 2003;18(3):550-556. 
doi:10.1093/humrep/deg096. 
38.  Gur Y, Breitbart H. Protein synthesis in sperm: Dialog between mitochondria and 
cytoplasm. Mol Cell Endocrinol. 2008;282(1-2):45-55. 
doi:10.1016/j.mce.2007.11.015. 
39.  Amikura R, Kashikawa M, Nakamura A, Kobayashi S. Presence of mitochondria-type 
ribosomes outside mitochondria in germ plasm of Drosophila embryos. Proc Natl 
Acad Sci. 2001;98(16):9133-9138. doi:10.1073/pnas.171286998. 
40.  St John JC, Bowles EJ, Amaral A. Sperm mitochondria and fertilisation. Soc Reprod 
Fertil Suppl. 2007;65(May):399-416. 
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt
=Citation&list_uids=17644980. 
41.  Hecht NB, Liem H, Kleene KC, Distel RJ, Ho S mei. Maternal inheritance of the mouse 
mitochondrial genome is not mediated by a loss or gross alteration of the paternal 
mitochondrial DNA or by methylation of the oocyte mitochondrial DNA. Dev Biol. 
1984;102(2):452-461. doi:10.1016/0012-1606(84)90210-0. 
42.  Cummins JM, Woodall PF. On mammalian sperm dimensions. J Reprod Fertil. 
1985;75(1):153-175. doi:10.1530/jrf.0.0750153. 
43.  Rouge M. Sperm Morphology. 
2004;17(1):http://www.vivo.colostate.edu/hbooks/pathphys/repr. 
http://www.vivo.colostate.edu/hbooks/pathphys/reprod/semeneval/morph.htmL. 
44.  Fardilha M, Esteves SLC, Korrodi-Gregório L, Pelech S, da Cruz e Silva OAB, da Cruz e 
Silva E. Protein phosphatase 1 complexes modulate sperm motility and present 
novel targets for male infertility. Mol Hum Reprod. 2011;17(8):466-477. 
doi:10.1093/molehr/gar004. 
45.  Ickowicz D, Finkelstein M, Breitbart H. Mechanism of sperm capacitation and the 
acrosome reaction: Role of protein kinases. Asian J Androl. 2012;14(6):816-821. 
doi:10.1038/aja.2012.81. 
46.  Suarez SS. Formation of a reservoir of sperm in the oviduct. Reprod Domest Anim. 
2002;37(3):140-143. doi:10.1046/j.1439-0531.2002.00346.x. 
47.  Hosken DJ, Hodgson DJ. Why do sperm carry RNA? Relatedness, conflict, and control. 
Trends Ecol Evol. 2014;29(8):451-455. doi:10.1016/j.tree.2014.05.006. 
48.  ImmLer S. Sperm competition and sperm cooperation: The potential role of diploid 
and haploid expression. Reproduction. 2008;135(3):275-283. doi:10.1530/REP-07-
0482. 
49.  Curry E, Safranski TJ, Pratt SL. Differential expression of porcine sperm microRNAs 
and their association with sperm morphology and motility. Theriogenology. 
2011;76(8):1532-1539. doi:10.1016/j.theriogenology.2011.06.025. 
50.  Vibranovski MD, Chalopin DS, Lopes HF, Long M, Karr TL. Direct evidence for 
postmeiotic transcription during Drosophila melanogaster spermatogenesis. 
Genetics. 2010;186(1):431-433. doi:10.1534/genetics.110.118919. 
  
 
42 
51.  Fischer BE, Wasbrough E, Meadows LA, et al. Conserved properties of Drosophila 
and human spermatozoal mRNA repertoires. Proc R Soc B Biol Sci. 
2012;279(1738):2636-2644. doi:10.1098/rspb.2012.0153. 
52.  Lewis S, South A. The Evolution of Animal Nuptial Gifts. Vol 44.; 2012. 
doi:10.1016/B978-0-12-394288-3.00002-2. 
53.  Birkhead TR, Hosken DJ, Pitnick S. Sperm Biology - An Evolutionary Perspective.; 
2009. 
54.  Crean AJ, Bonduriansky R. What is a paternal effect? Trends Ecol Evol. 
2014;29(10):554-559. doi:10.1016/j.tree.2014.07.009. 
55.  Holman L, Price TAR. Even more functions of sperm RNA: A response to Hosken and 
Hodgson. Trends Ecol Evol. 2014;29(12):648-649. doi:10.1016/j.tree.2014.09.014. 
56.  Burt A, Trivers RL. Genes in Conflict: The Biology of Selfish Genetic Elements. Vol 82. 
Paperback. Cambridge; 2006. doi:10.1086/523135. 
57.  Zhao C, Guo XJ, Shi ZH, et al. Role of translation by mitochondrial-type ribosomes 
during sperm capacitation: An analysis based on a proteomic approach. Proteomics. 
2009;9(5):1385-1399. doi:10.1002/pmic.200800353. 
58.  Schmidt EK, Clavarino G, Ceppi M, Pierre P. SUnSET, a nonradioactive method to 
monitor protein synthesis. Nat Methods. 2009;6(4):275-277. 
doi:10.1038/nmeth.1314. 
59.  Nathans D. Puromycin inhibition of protein synthesis: incorporation of puromycin 
into peptide chains. Proc Natl Acad Sci. 1964;51(1963):585-592. 
60.  Nemoto N, Miyamoto-Sato E, Husimi Y, Yanagawa H. In vitro virus: Bonding of mRNA 
bearing puromycin at the 3’-terminal end to the C-terminal end of its encoded 
protein on the ribosome in vitro. FEBS Lett. 1997;414(2):405-408. 
doi:10.1016/S0014-5793(97)01026-0. 
61.  Starck SR, Roberts RW. Puromycin oligonucleotides reveal steric restrictions for 
ribosome entry and multiple modes of translation inhibition. Rna. 2002;8(7):890-
903. doi:10.1017/S1355838202022069. 
62.  Lelouard H, Ferrand V, Marguet D, et al. Dendritic cell aggresome-like induced 
structures are dedicated areas for ubiquitination and storage of newly synthesized 
defective proteins. J Cell Biol. 2004;164(5):667-675. doi:10.1083/jcb.200312073. 
63.  Betters, PhD, RN DM. Use of Flow Cytometry in Clinical Practice. J Adv Pract Oncol. 
2015;6(5):435-440. doi:10.6004/jadpro.2015.6.5.4. 
64.  Smith GD, Wolf DP, Trautman KC, da Cruz e Silva EF, Greengard P, Vijayaraghavan S. 
Primate sperm contain protein phosphatase 1, a biochemical mediator of motility. 
Biol Reprod. 1996;54:719-727. doi:10.1095/biolreprod54.3.719. 
65.  Vijayaraghavan S, Mohan J, Gray H, Khatra B, Carr DW. A Role for Phosphorylation 
of Glycogen Synthase Kinase-3α in Bovine Sperm Motility Regulation. Biol Reprod. 
2000;62:1647-1654. doi:10.1095/biolreprod62.6.1647. 
66.  Naor Z, Breitbart H. Protein kinase C and mammalian spermatozoa acrosome 
reaction. Trends Endocrinol Metab. 1997;8(9):337–42. doi:10.1016/S1043-
2760(97)00134-3. 
67.  Breitbart H, Lax J, Rotem R, Naor Z. Role of protein kinase C in the acrosome reaction 
of mammalian spermatozoa. Biochem J. 1992;281 ( Pt 2:473-476. 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1130709&tool=pmce
  
 
43 
ntrez&rendertype=abstract. 
68.  Rotem R, Paz GF, Homonnai ZT, Kalina M, Lax J, Breitbart H NZ. Ca2+-Independent 
Induction Protein Kinase C in Human sperm. Endocrinology. 1992;131(5):2235-2243. 
69.  Marin-Briggiler CI. Evidence of the presence of calcium/calmodulin-dependent 
protein kinase IV in human sperm and its involvement in motility regulation. J Cell 
Sci. 2005;118(9):2013-2022. doi:10.1242/jcs.02326. 
70.  Silva JV, Freitas MJ, Correia BR, et al. Profiling signaling proteins in human 
spermatozoa: Biomarker identification for sperm quality evaluation. Fertil Steril. 
2015;104(4):845-856e8. doi:10.1016/j.fertnstert.2015.06.039. 
71.  Feng LX, Ravindranath N, Dym M. Stem cell factor/c-kit up-regulates cyclin D3 and 
promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase 
pathway in spermatogonia. J Biol Chem. 2000;275(33):25572-25576. 
doi:10.1074/jbc.M002218200. 
72.  David A, Dolan BP, Hickman HD, et al. Nuclear translation visualized by ribosome-
bound nascent chain puromycylation. J Cell Biol. 2012;197(1):45-57. 
doi:10.1083/jcb.201112145. 
73.  Aviner R, Geiger T, Elroy-Stein O. Novel proteomic approach (PUNCH-P) reveals cell 
cycle-specific fluctuations in mRNA translation. Genes Dev. 2013;27(16):1834-1844. 
doi:10.1101/gad.219105.113. 
74.  Hobden AN, Cundliffe E. The mode of action of alpha sarcin and a novel assay of the 
puromycin reaction. Biochem J. 1978;170(1):57-61. doi:10.1042/bj1700057. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary data 
 
 
 
44 
Supplementary data 
 
Supplementary Table 1 – Solutions used in the experiments. 
 
Surface Sensing of Translation (SUnSET) 
Puromycin 100 ug/mL For 10 mL, dissolve 1 mg of puromycin in 10 mL 
deionized water. 
Flow Cytometry analysis 
4% Paraformaldehyde (PFA) For 15 mL, dissolve 1,5 mL of PFA stock 37% in 13,5 
mL PBS. 
Fluorescence activated cell sorting (FACS) solution 
including 0,1% saponin 
For 10 mL dissolve 0,025 g of BSA in 5 mL of PBS 
and add 2 mL saponin and 0,1 mL sodium azide 
and make up to 10 mL with PBS. 
Anti-puromycin Alexa488 diluted in 1:100 FACS 
solution 
For 250 ul, add 2,5 ul Anti-Puromicina-Alexa488 to 
250 ul FACS solution. 
Sperm treatment with translation inhibitors 
D-Chloramphenicol 100 µg/mL For 1 mL, dissolve 1 mg d-chloramphenicol in 1 mL 
ethanol, add 9 mL MiliQ water. 
Cycloheximide 1 mg/mL For 1 mL, dissolve 1 mg cycloheximide in 1 mL 
deionized water. 
Western Blotting 
Running gel 12% (2 gels, 1.5 mm thickness) ddH2O 
Tris 1.5 M pH8.8 
Acrylamide 40% 
Bisacrylamide 2% 
SDS 10% 
APS 10% 
TEMED 
6.360 mL 
5.000 mL 
5.880 mL 
2.360 mL 
0.200 mL 
0.100 mL 
0.020 mL 
Stacking gel 4% (2 gels, 1.5 mm thickness) ddH2O 
Tris 0.5 M pH6.8 
Acrylamide 40% 
Bisacrylamide 2% 
SDS 10% 
APS 10% 
TEMED 
4.736 mL 
2.000 mL 
0.784 mL 
0.320 mL 
0.080 mL 
0.040 mL 
0.008 mL 
 
Tris-HCl 1.5 M pH 8.8 buffer For 1 L dissolve 181.5 g Tris in 800 mL deionized 
water. Adjust pH at 8.8 with HCl and make up to 1 L 
with deionized water. 
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Tris-HCl 0.5 M pH 6.8 buffer For 1 L dissolve 60 g Tris in 800 mL deionized water. 
Adjust pH at 6.8 with HCl and make up to 1 L with 
deionized water. 
10% APS (ammonium persulfate) For 10 mL of deionized water add 1 g of APS. 
10% SDS (sodium dodecilsulfate) For 500 mL of deionized water dissolve 50 g of SDS. 
4X Loading gel buffer For 10 mL add 44 mL glycerol, 250 µL Tris-HCl 0.5 M 
pH 6.8 buffer, 0.8 g SDS, 0.2 mL β-mercaptoethanol 
and 3.3 mL deionized water. Add bromophenol blue 
(a small amount). Keep it at RT for short periods or 
at 4ºC for longer periods.  
Tris-Gly 10X Stock For 1 L dissolve 30.30 g Tris (250 mM) and 144.10 g 
Gly (1.92 M) in 1 L of deionized water.  
Running buffer 1X For 1 L add 800 mL deionized water, 100 mL Tris-Gly 
10X and 10 mL 10%SDS. Make up to 1 L with 
deionized water. 
Transfer buffer 1X For 1 L add 100 mL Tris-Gly 10X to 700 mL of 
deionized water and 200 mL methanol.  
10X TBS Stock (Tris buffered saline) For 0.5 L dissolve 6.055g Tris in deionized water and 
adjust pH at 8.0. Add 43.8325 g NaCl and make up 
to 500 mL with deionized water.  
1X TBST (TBS + Tween 20) For 1 L add 100 mL TBS 10X and 500 µL Tween-20 to 
900 mL of deionized water. 
5% BSA in TBST 1X For 100 mL of solution dissolve 5 g of BSA in TBST 
1X. 
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Supplementary Table 2 – Results of basic human spermatozoa analysis. 
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Sample 1 5,5 43 23 34 22 5 90 62 22 
Sample 2 4 63 16 21 108 8 85 55 8 
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Supplementary Table 3 – Results of basic human spermatozoa analysis between 
time 0 (T0) and 4h incubation with D-CP.  
 
 T0 D-CP 4h 
Progressive motility (%) 69,11 58,48 
Non-progressive motility (%) 21,43 18,71 
Immotile (%) 9,46 22,81 
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Supplementary Figure 1 - Ponceau S. staining used as loading control for 
Immunoblot with mouse anti-GSK-3α/β and rabbit anti-PPP1CC2 (A); mouse anti-
HSP27 (B); mouse anti-CaMKIV (C). 
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Supplementary Figure 2 - Immunoblot with mouse anti-PKC BI (A) revealed no 
staining in bovine spermatozoa; Ponceau S. staining used as loading control for 
Immunoblot with mouse anti-PKC BI (B). 
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Supplementary Figure 3 - Immunoblot with mouse anti-p70 S6 kinase α (A) revealed 
no staining in bovine spermatozoa; Ponceau S. staining used as loading control for 
Immunoblot with mouse anti-p70 S6 kinase α (B). 
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Supplementary Figure 4 - Protein translation in spermatozoa poster exhibited in I 
NoTeS Congress - Novel therapeutic strategies for noncommunicable diseases, 22-
23 June 2018 
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Background
• Protein translation occurs in human and bovine spermatozoa during capacitation
• Mitochondrial and cytoplasmic ribosomes are involved in spermatozoa protein
translation
• First time, PPP1CC2 and HSP27 were shown to be translated in spermatozoa
during capacitation
Conclusions
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Results
Reversible protein phosphorylation is the key general mechanism for regulating vital sperm cells functions since sperm cells are highly compartmentalized and almost devoid of
transcription and translation 1. However, in the neck region of spermatozoa, there is a small area of uncondensed chromatin where transcription, translation and protein-
biosynthesis are still possible 2,3,4. A new insight was recently given showing protein synthesis in spermatozoa during capacitation 5. Protein production in spermatozoa revealed
to be sensitive to several mitochondrial mRNA translation inhibitors such as D-chloramphenicol, gentamycin and tetracycline, although insensitive to the cytoplasmic 80S
ribosomal inhibitor cycloheximide. Furthermore, translation was unaffected by transcription inhibitor suggesting that the source of mRNA for protein translation is long lasting
mRNA 5.
Figure 5 – Immunoblots with mouse anti-GSK-3α/β (A,B), anti-HSP27 (E,F), anti-CaMKIV (G,H) and
rabbit anti-PPP1CC2 (C,D). Spz, spermatozoa; puro, puromycin; NC, negative control; D-CP, D-
Chloramphenicol; CH, cycloheximide; IB, immunoblot.
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• Identification of the proteins translated in human spermatozoa by mass
spectrometry
• Validate mitochondrial and cytoplasmic ribosomes function in spermatozoa
protein translation, with other translation elongation inhibitors
Human and bovine spermatozoa were treated, under capacitation conditions, with different puromycin concentrations with or without translation inhibitor (D-
chloramphenicol). Samples were then analysed using the SUnSET technique, which allows to monitor the rate of mRNA translation by puromycin incorporation in
neosynthesized proteins. Puromycin incorporation was detected by Flow Cytometry with an anti-puromycin antibody (Figure 1-4) 6.
To assess the impact of translation inhibition on the levels of signaling proteins, bovine spermatozoa was incubated under capacitation conditions with or without D-
chloramphenicol or cycloheximide. Sperm cells lysates were then electrophoresed and membranes were incubated with antibodies for GSK-3∝ /β, PPP1CC2, CaMKIV and
HSP27 (Figure 5).
Figure 1 – Overlay histograms of human spermatozoa (A) and PNT2
cells (PC) (B). Human spermatozoa and PNT2 cells were treated with
puromycin for 15 min. Spz, spermatozoa; PC, positive control; NC,
negative control; puro, puromycin.
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Figure 4 – Overlay and puromycin incorporation (MFI) (B) histograms
of bovine spermatozoa (A) between stained for anti-IgG or anti-
puromycin samples. Bovine spermatozoa were treated with
puromycin and with or without D-chloramphenicol for 30 min or 4 h.
Spz, spermatozoa; IC, isotype control; PC, positive control; NC,
negative control; puro, puromycin.
Protein translation occurs in human spermatozoa 
GSK-3α, PPP1CC2 and HSP27 are translated, while CaMKIV remains relatively stable during sperm capacitation
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Figure 2 – Overlay and puromycin incorporation (MFI) (C) histograms
of bovine spermatozoa (A) and PNT2 cells (PC) (B). Bovine
spermatozoa and PNT2 cells were treated with different puromycin
concentrations for 15 min. Spz, spermatozoa; PC, positive control;
NC, negative control; puro, puromycin.
Figure 3 – Overlay and puromycin incorporation (MFI) (B) histograms
of bovine spermatozoa (A). Bovine spermatozoa were treated with
different puromycin concentrations for 30 min. Spz, spermatozoa;
PC, positive control; NC, negative control; puro, puromycin.
